Evaluating the Efficacy of Nicotine Patch Therapy in Promoting Long-Term Cessation

Description

This study aims to investigate the effectiveness of a high-dose nicotine patch therapy in supporting individuals who use smokeless ‘chewing’ tobacco to quit either long-term or permanently. Smokeless tobacco products carry significant health risks, including heightened risks for oral cancers, cardiovascular issues, and other adverse health outcomes. Despite these risks, users often struggle with the strong nicotine dependency associated with smokeless tobacco.

The goal of this clinical trial is to determine whether high-dose nicotine patch therapy can provide an effective cessation tool specifically tailored for smokeless tobacco users, potentially offering a pathway to reduce dependency and achieve lasting abstinence. Participants will receive counseling and a tailored regimen of nicotine patches, with a focus on gradually reducing nicotine intake to manage withdrawal symptoms effectively.

If this therapy proves effective, it could serve as a valuable resource for individuals looking to quit smokeless tobacco use, ultimately helping reduce their risk for the severe health issues linked to this form of tobacco. Participants will also contribute to valuable research that may influence future cessation treatment protocols specifically designed for smokeless tobacco users.